ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc (XENE)

41,15
1,35
(3,39%)
Geschlossen 24 November 10:00PM
43,00
1,85
(4,50%)
Nach Börsenschluss: 1:59AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
41,15
Gebot
27,99
Fragen
66,01
Volumen
335.421
39,665 Tagesbereich 41,62
28,2005 52-Wochen-Bereich 50,99
Marktkapitalisierung
Handelsende
39,80
Handelsbeginn
40,06
Letzte Trade
4
@
43.2
Letzter Handelszeitpunkt
Finanzvolumen
US$ 13.719.330
VWAP
40,9018
Durchschnittliches Volumen (3 Mio.)
362.656
Ausgegebene Aktien
76.239.602
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-17,20
Gewinn pro Aktie (EPS)
-2,39
Erlöse
-
Nettogewinn
-182,39M

Über Xenon Pharmaceuticals Inc

Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets. Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Burnaby, British Columbia, Can
Gegründet
-
Xenon Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XENE. The last closing price for Xenon Pharmaceuticals was US$39,80. Over the last year, Xenon Pharmaceuticals shares have traded in a share price range of US$ 28,2005 to US$ 50,99.

Xenon Pharmaceuticals currently has 76.239.602 shares in issue. The market capitalisation of Xenon Pharmaceuticals is US$3,03 billion. Xenon Pharmaceuticals has a price to earnings ratio (PE ratio) of -17.20.

Option-Flow Xenon Pharmaceuticals (XENE)

Gesamtfluss

Bärisch

Nettoprämie

-16k

Calls / Puts

100,00%

Käuf. / Verkä.

0,00%

OTM / ITM

100,00%

Sweeps

0,00%

XENE Neueste Nachrichten

Xenon to Present at Upcoming Investor Conferences

VANCOUVER, British Columbia and BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering...

Xenon Reports Q3 2024 Financial Results and Business Update

– Phase 3 epilepsy program advancing with X-TOLE2 topline FOS data anticipated in H2 2025 – Long-term azetukalner results from X-TOLE open-label extension study in FOS to be presented at AES –...

Xenon to Report Q3 2024 Financial Results on November 12, 2024

VANCOUVER, British Columbia and BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering...

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

VANCOUVER, British Columbia and BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering...

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

Three presentations highlighting long-term data and improved quality of life outcomes in adults with focal onset seizures VANCOUVER, British Columbia and BOSTON, Sept. 09, 2024 (GLOBE NEWSWIRE...

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

VANCOUVER, British Columbia and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.19-0.45960328979241.344337.3453644539.09518812CS
4-0.75-1.7899761336541.94637.3440200941.5477451CS
120.92.2360248447240.254637.3436265640.9798301CS
262.055.2429667519239.14635.5338881840.20577277CS
5210.9636.303411725730.1950.9928.200543487741.48458674CS
15612.2642.436829352728.8950.9923.2642736136.62445477CS
26031.75337.7659574479.450.99743025131.67432647CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PDYNPalladyne AI Corporation
US$ 4,59
(129,50%)
83M
QMCOQuantum Corporation
US$ 9,11
(126,62%)
39,41M
NANano Labs Ltd
US$ 8,26
(89,02%)
2,03M
XCURExicure Inc
US$ 18,60
(71,27%)
4,36M
SKKSKK Holdings Limited
US$ 1,75
(59,09%)
95,06M
AMIXAutonomix Medical Inc
US$ 6,21
(-54,07%)
897,51k
CETXCemtrex Inc
US$ 0,1146
(-41,74%)
22,89M
MSWMing Shing Group Holdings Ltd
 5,90
(-35,52%)
417,08k
RMSGReal Messenger Corporation
US$ 3,09
(-26,25%)
305,85k
ENSCEnsysce Biosciences Inc
US$ 0,4414
(-25,49%)
3,93M
ELABElevai Labs Inc
US$ 0,0201
(-0,50%)
415,87M
NVDANVIDIA Corporation
US$ 141,95
(-3,22%)
229,93M
SMCISuper Micro Computer Inc
US$ 33,15
(11,62%)
155,43M
VRPXVirpax Pharmaceuticals Inc
US$ 0,5501
(-6,72%)
154,17M
SOUNSoundHound AI Inc
US$ 8,24
(18,05%)
103,6M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock